Emerging Role of Hypoxia-Induced Autophagy in Cancer Immunotherapy

Autophagy: Cancer, Other Pathologies, Inflammation, Immunity, Infection, and Aging

Volumn 3, Issue , 2014, Pages 247-262

  Janji, Bassam ^a   Noman, Muhammad Zaeem ^b   Viry, Elodie ^a   Hasmim, Meriem ^b   Messai, Yosra ^b   Berchem, Guy ^a   Chouaib, Fathia Mami ^b   Chouaib, Salem ^b  

^a Public Research Center for Health   (Luxembourg)

^b INSERM   (France)

Author keywords

Antigen Presenting Cells (APCs); Cancer Immunotherapy; Hypoxia Inducible Factors (HIFs); Lymphocytes; Myeloid Cells; Neutrophils; T Lymphocytes

Indexed keywords

EID: 84908160102     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-405529-2.00017-2     Document Type: Chapter

References (31)

1. Acker T., Fandrey J., Acker H. The good, the bad and the ugly in oxygen-sensing: ROS, cytochromes and prolyl-hydroxylases. Cardiovas. Res. 2006, 71:195-207.
2. Amaravadi R.K., Lippincott-Schwartz J., Yin X.M., et al. Principles and current strategies for targeting autophagy for cancer treatment. Clin. Cancer Res. 2011, 17:654-666.
3. Bingle L., Brown N.J., Lewis C.E. The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. J. Pathol. 2002, 196:254-265.
4. Ferrone S., Whiteside T.L. Tumor microenvironment and immune escape. Surg. Oncol. Clin. N. Am. 2007, 16:755-774. viii.
5. Flavell R.A., Sanjabi S., Wrzesinski S.H., et al. The polarization of immune cells in the tumour environment by TGFbeta. Nat. Rev. Immunol. 2010, 10:554-567.
6. Gabrilovich D. Mechanisms and functional significance of tumour-induced dendritic-cell defects. Nat. Rev. Immunol. 2004, 4:941-952.
7. Gale D.P., Maxwell P.H. The role of HIF in immunity. Int. J. Biochem. Cell Biol. 2010, 42:486-494.
8. Hasmim M., Noman M.Z., Lauriol J., et al. Hypoxia-dependent inhibition of tumor cell susceptibility to CTL-mediated lysis involves NANOG induction in target cells. J. Immunol. 2011, 187:4031-4039.
9. Kimmelman A.C. The dynamic nature of autophagy in cancer. Genes Dev. 2011, 25:1999-2010.
10. Kuballa P., Nolte W.M., Castoreno A.B., et al. Autophagy and the immune system. Annu. Rev. Immunol. 2012, 30:611-646.
11. Laconi E. The evolving concept of tumor microenvironments. Bioessays 2007, 29:738-744.
12. Lee K., Kim H.M. A novel approach to cancer therapy using PX-478 as a HIF-1alpha inhibitor. Arch. Pharm. Res. 2011, 34:1583-1585.
13. Mancino A., Schioppa T., Larghi P., et al. Divergent effects of hypoxia on dendritic cell functions. Blood 2008, 112:3723-3734.
14. Mazure N.M., Pouyssegur J. Hypoxia-induced autophagy: cell death or cell survival?. Curr. Opin. Cell Biol. 2010, 22:177-180.
15. Mellman I., Coukos G., Dranoff G. Cancer immunotherapy comes of age. Nature 2011, 480:480-489.
16. Mihalache C.C., Yousefi S., Conus S., et al. Inflammation-associated autophagy-related programmed necrotic death of human neutrophils characterized by organelle fusion events. J. Immunol. 2011, 186:6532-6542.
17. Noman M.Z., Buart S., Van Pelt J., et al. The cooperative induction of hypoxia-inducible factor-1 alpha and STAT3 during hypoxia induced an impairment of tumor susceptibility to CTL-mediated cell lysis. J. Immunol. 2009, 182:3510-3521.
18. Noman M.Z., Benlalam H., Hasmim M., et al. Cytotoxic T cells-stroma interactions. Bull. Cancer 2011, 98:E19-E24.
19. Noman M.Z., Janji B., Kaminska B., et al. Blocking hypoxia-induced autophagy in tumors restores cytotoxic T-cell activity and promotes regression. Cancer Res. 2011, 71:5976-5986.
20. Noman M.Z., Messai Y., Carre T., et al. Microenvironmental hypoxia orchestrating the cell stroma cross talk, tumor progression and antitumor response. Crit. Rev. Immunol. 2011, 31:357-377.
21. Noman M.Z., Buart S., Romero P., et al. Hypoxia-inducible miR-210 regulates the susceptibility of tumor cells to lysis by cytotoxic T cells. Cancer Res. 2012, 72:4629-4641.
22. Noman M.Z., Janji B., Berchem G., et al. Hypoxia-induced autophagy: a new player in cancer immunotherapy?. Autophagy 2012, 8:704-706.
23. Notte A., Leclere L., Michiels C. Autophagy as a mediator of chemotherapy-induced cell death in cancer. Biochem. Pharmacol. 2011, 82:427-434.
24. Palazon A., Aragones J., Morales-Kastresana A., et al. Molecular pathways: hypoxia response in immune cells fighting or promoting cancer. Clin. Cancer Res. 2012, 18:1207-1213.
25. Schlie K., Spowart J.E., Hughson L.R., et al. When cells suffocate: autophagy in cancer and immune cells under low oxygen. Int. J. Cell Biol. 2011, 2011. 470597.
26. Schodel J., Oikonomopoulos S., Ragoussis J., et al. High-resolution genome-wide mapping of HIF-binding sites by ChIP-seq. Blood 2011, 117:e207-e217.
27. Scott A.M., Wolchok J.D., Old L.J. Antibody therapy of cancer. Nat. Rev. Cancer 2012, 12:278-287.
28. Semenza G.L. Hypoxia, clonal selection, and the role of HIF-1 in tumor progression. Crit. Rev. Biochem. Mol. Biol. 2000, 35:71-103.
29. Shiao S.L., Ganesan A.P., Rugo H.S., et al. Immune microenvironments in solid tumors: new targets for therapy. Genes Dev. 2011, 25:2559-2572.
30. Siemens D.R., Hu N., Sheikhi A.K., et al. Hypoxia increases tumor cell shedding of MHC class I chain-related molecule: role of nitric oxide. Cancer Res. 2008, 68:4746-4753.
31. Townsend K.N., Hughson L.R., Schlie K., et al. Autophagy inhibition in cancer therapy: metabolic considerations for antitumor immunity. Immunol. Rev. 2012, 249:176-194.